geneCORE Predict Comprehensive Advance

geneCORE Predict Comprehensive Advance is a specialized blood test that uses Next Generation Sequencing (NGS) & digitalMLPA technology to detect copy number variations (CNVs) in 28 clinically relevant oncogenes associated with hereditary predisposition (those passing from generation to generation) to one or more of various cancer types including breast, ovarian, colorectal, gastric, prostate, pancreatic, endometrial, and melanoma. It has two components, namely, geneCŌRE Predict Advance and geneCŌRE Predict digitalMLPA. geneCORE Predict Comprehensive Advance also allows for the detection of 4 common mutations in clinically relevant oncogenes. The test is usually advised for individuals with personal and/or family history of cancer.

Note: Genetic counseling can be provided. If interested please send the request to this email id: [email protected]